Features of patients who developed hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C Virus.

<h4>Background</h4>The features of hepatitis C virus patients with a sustained virologic response (SVR) who developed hepatocellular carcinoma (HCC) after direct-acting antiviral (DAA) therapy are unclear.<h4>Methods</h4>The study population included 1494 DAA-SVR patients without a history of HCC. T...

Deskribapen osoa

Gorde:

Xehetasun bibliografikoak
Egile Nagusiak:	Seiichi Mawatari, Kotaro Kumagai, Kohei Oda, Kazuaki Tabu, Sho Ijuin, Kunio Fujisaki, Shuzo Tashima, Yukiko Inada, Hirofumi Uto, Akiko Saisyoji, Yasunari Hiramine, Masafumi Hashiguchi, Tsutomu Tamai, Takeshi Hori, Ohki Taniyama, Ai Toyodome, Haruka Sakae, Takeshi Kure, Kazuhiro Sakurai, Akihiro Moriuchi, Shuji Kanmura, Akio Ido
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Public Library of Science (PLoS) 2022-01-01
Saila:	PLoS ONE
Sarrera elektronikoa:	https://doi.org/10.1371/journal.pone.0262267
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Features of patients who developed hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C Virus.

Antzeko izenburuak